These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 23728588)
61. In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in mice. Arazi A; Sharabi A; Zinger H; Mozes E; Neumann AU PLoS One; 2009 Dec; 4(12):e8447. PubMed ID: 20041142 [TBL] [Abstract][Full Text] [Related]
62. Protective effect of CD4(+)CD25(high)CD127(low) regulatory T cells in renal ischemia-reperfusion injury. Jun C; Ke W; Qingshu L; Ping L; Jun D; Jie L; Bo C; Su M Cell Immunol; 2014; 289(1-2):106-11. PubMed ID: 24754976 [TBL] [Abstract][Full Text] [Related]
63. CD4+CD25+ and CD4+CD2+high regulatory T cells in disseminated and localized forms of allergic contact dermatitis: relation to specific cytokines. Reduta T; Stasiak-Barmuta A; Laudańska H Folia Histochem Cytobiol; 2011; 49(2):255-62. PubMed ID: 21744325 [TBL] [Abstract][Full Text] [Related]
64. Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4 Ge Y; Huang M; Wu Y; Dong N; Yao YM J Cell Mol Med; 2020 Jan; 24(2):2027-2039. PubMed ID: 31880383 [TBL] [Abstract][Full Text] [Related]
65. CD4+/CD25(high)/FoxP3+/CD127- regulatory T cells in bronchoalveolar lavage fluid of lung cancer patients. Osińska I; Stelmaszczyk-Emmel A; Polubiec-Kownacka M; Dziedzic D; Domagała-Kulawik J Hum Immunol; 2016 Oct; 77(10):912-915. PubMed ID: 27474372 [TBL] [Abstract][Full Text] [Related]
66. The relationship between CD4+CD25+CD127- regulatory T cells and inflammatory response and outcome during shock states. Hein F; Massin F; Cravoisy-Popovic A; Barraud D; Levy B; Bollaert PE; Gibot S Crit Care; 2010; 14(1):R19. PubMed ID: 20156359 [TBL] [Abstract][Full Text] [Related]
68. Isolation of Human Regulatory T Lymphocytes by Fluorescence-Activated Cell Sorting. Milward K; Hester J; Wood KJ Methods Mol Biol; 2019; 1899():43-54. PubMed ID: 30649764 [TBL] [Abstract][Full Text] [Related]
69. [Abnormal quantity of regulatory T cells in peripheral blood of patients with severe aplastic anemia and its clinical significance]. Qi WW; Fu R; Wang HQ; Liu CY; Ren Y; Tao JL; Shao ZH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1043-6. PubMed ID: 25130825 [TBL] [Abstract][Full Text] [Related]
70. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy. Stelmaszczyk-Emmel A; Zawadzka-Krajewska A; Szypowska A; Kulus M; Demkow U Int Arch Allergy Immunol; 2013; 162(1):16-24. PubMed ID: 23817221 [TBL] [Abstract][Full Text] [Related]
71. Immunophenotyping of Human Regulatory T Cells. Staats J Methods Mol Biol; 2019; 2032():141-177. PubMed ID: 31522418 [TBL] [Abstract][Full Text] [Related]
72. Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients. Derhovanessian E; Adams V; Hähnel K; Groeger A; Pandha H; Ward S; Pawelec G Int J Cancer; 2009 Sep; 125(6):1372-9. PubMed ID: 19533748 [TBL] [Abstract][Full Text] [Related]
73. Non-traditional CD4+CD25-CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation. Zhao XS; Wang XH; Zhao XY; Chang YJ; Xu LP; Zhang XH; Huang XJ J Transl Med; 2014 Jul; 12():187. PubMed ID: 24984576 [TBL] [Abstract][Full Text] [Related]
74. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185 [TBL] [Abstract][Full Text] [Related]
75. Significance of immunoregulatory T cells in different stages of breast cancer patients. Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697 [TBL] [Abstract][Full Text] [Related]
76. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells. Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563 [TBL] [Abstract][Full Text] [Related]
77. T-regulatory lymphocytes in peripheral blood of gastric and colorectal cancer patients. Szczepanik AM; Siedlar M; Sierzega M; Goroszeniuk D; Bukowska-Strakova K; Czupryna A; Kulig J World J Gastroenterol; 2011 Jan; 17(3):343-8. PubMed ID: 21253393 [TBL] [Abstract][Full Text] [Related]
78. Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF). Yang J; Yi P; Wei L; Xu Z; Chen Y; Tang L; Li L J Transl Med; 2012 Sep; 10():193. PubMed ID: 22978653 [TBL] [Abstract][Full Text] [Related]
79. Induction of M2-like macrophages in recipient NOD-scid mice by allogeneic donor CD4(+)CD25(+) regulatory T cells. Hu X; Liu G; Hou Y; Shi J; Zhu L; Jin D; Peng J; Zhao Y Cell Mol Immunol; 2012 Nov; 9(6):464-72. PubMed ID: 23085944 [TBL] [Abstract][Full Text] [Related]
80. Reduced CD4 Mirzakhani M; Shahbazi M; Akbari R; Oliaei F; Asgharpour M; Nikoueinejad H; Mohammadnia-Afrouzi M Transpl Immunol; 2020 Jun; 60():101290. PubMed ID: 32240775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]